全文获取类型
收费全文 | 161042篇 |
免费 | 9939篇 |
国内免费 | 3248篇 |
专业分类
耳鼻咽喉 | 1212篇 |
儿科学 | 2937篇 |
妇产科学 | 1671篇 |
基础医学 | 16026篇 |
口腔科学 | 4296篇 |
临床医学 | 18645篇 |
内科学 | 27048篇 |
皮肤病学 | 2111篇 |
神经病学 | 10354篇 |
特种医学 | 4846篇 |
外国民族医学 | 8篇 |
外科学 | 18810篇 |
综合类 | 20672篇 |
现状与发展 | 10篇 |
一般理论 | 6篇 |
预防医学 | 13068篇 |
眼科学 | 2208篇 |
药学 | 13274篇 |
130篇 | |
中国医学 | 12598篇 |
肿瘤学 | 4299篇 |
出版年
2023年 | 2163篇 |
2022年 | 3597篇 |
2021年 | 6001篇 |
2020年 | 5082篇 |
2019年 | 8195篇 |
2018年 | 8465篇 |
2017年 | 6617篇 |
2016年 | 4354篇 |
2015年 | 4138篇 |
2014年 | 8025篇 |
2013年 | 8334篇 |
2012年 | 6998篇 |
2011年 | 7394篇 |
2010年 | 5953篇 |
2009年 | 5121篇 |
2008年 | 5146篇 |
2007年 | 5297篇 |
2006年 | 4694篇 |
2005年 | 4131篇 |
2004年 | 3637篇 |
2003年 | 3454篇 |
2002年 | 2789篇 |
2001年 | 2776篇 |
2000年 | 2227篇 |
1999年 | 2013篇 |
1998年 | 1656篇 |
1997年 | 1731篇 |
1996年 | 1426篇 |
1995年 | 1431篇 |
1994年 | 1313篇 |
1993年 | 1004篇 |
1992年 | 977篇 |
1991年 | 861篇 |
1990年 | 682篇 |
1989年 | 654篇 |
1988年 | 625篇 |
1987年 | 535篇 |
1985年 | 3451篇 |
1984年 | 3895篇 |
1983年 | 3201篇 |
1982年 | 3796篇 |
1981年 | 3363篇 |
1980年 | 2832篇 |
1979年 | 2719篇 |
1978年 | 2257篇 |
1977年 | 1698篇 |
1976年 | 2147篇 |
1975年 | 1587篇 |
1974年 | 1383篇 |
1973年 | 1322篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
目的探讨8周基础军训(basic military training,BMT)对入伍新兵血像中红细胞及其相关指标的影响,为指导科学的军事训练提供参考。方法数据来自新疆边防部队2015年度入伍的50名男性新兵,分别在BMT前后测定并记录受试新兵的红细胞计数、血红蛋白浓度及血清铁蛋白等。结果经过8周的BMT,新兵血液中血红蛋白浓度、红细胞计数及血清铁蛋白均显著下降(P0.05,P0.01)。结论 8周BMT可能导致入伍新兵发生运动性贫血,铁缺乏可能是其主要原因。 相似文献
83.
84.
85.
86.
目的:探究替米沙坦对冠心病合并糖尿病肾病患者疗效的影响情况。方法:56例探究目标对象均为某院接收的冠心病合并糖尿病肾病患者,挑选时间2018年6月~2019年6月。将"计算机表法"作为分组的参考,分配为参照组(n=28例)执行依那普利治疗,探究组(n=28例)执行替米沙坦治疗。结果:探究组的LVEF、LVEDd、肌酐、24h尿蛋白4项指标与参照组相比,差异有统计学意义(P<0.05);收缩压、舒张压、空腹血糖、餐后2h血糖4项指标与参照组相比,差异没有统计学意义(P>0.05)。结论:冠心病合并糖尿病肾病患者选择替米沙坦治疗后,心室功能的重构以及肾脏预后结局均得到改善,且临床效果比依那普利好,值得借鉴。 相似文献
87.
Takashi Murakami Naoto Sakamoto Akihito Nagahara 《Journal of gastroenterology and hepatology》2019,34(10):1685-1695
Sessile serrated adenoma/polyps (SSA/Ps) are early precursor lesions in the serrated neoplasia pathway, which results in BRAF‐mutated colorectal carcinomas with not only high levels of microsatellite instability but also microsatellite stable. SSA/Ps with advanced histology, including cytological dysplasia or minimally invasive carcinomas, are important lesions because SSA/Ps are considered major contributors to “interval cancers” and these lesions can rapidly become dysplastic or invasive carcinomas. Clinicopathologically, SSA/Ps with dysplasia or invasive carcinoma were associated with advanced age, female sex, and proximal colon. Although SSA/Ps with submucosal invasive carcinoma were smaller and invaded less deeply into the submucosal layer than conventional tubular adenomas with submucosal invasive carcinoma, SSA/Ps with submucosal invasive carcinoma frequently had a mucinous component and exhibited a higher potential for lymphatic invasion and lymph node metastasis. In an SSA/P series, endoscopic characteristics, including (semi)pedunculated morphology, double elevation, central depression, and reddishness, may help accurately diagnose SSA/Ps with advanced histology. Removal of SSA/Ps with dysplasia or invasive carcinoma was recommended. Endoscopic treatment such as endoscopic mucosal resection or endoscopic submucosal dissection is useful for those lesions. However, surgical resection with lymph node dissection might be indicated when SSA/Ps with invasive carcinoma are endoscopically suspected, because these have the high risk of lymph node metastasis. Greater awareness may promote further research into improving the detection, recognition, and complete resection rates of SSA/Ps with dysplasia or invasive carcinoma and reduce the interval cancer rates. 相似文献
88.
89.
90.
《Clinical Lymphoma, Myeloma & Leukemia》2020,20(8):e461-e467
IntroductionVon Willebrand factor (vWF) cleaving protease ADAMTS-13 has a key role for maintaining normal size of vWF. A deficiency or dysfunction of vWF cleaving protease is associated with ultra large vWF multimers and thrombotic microangiopathy. Patients with cancers have reduced levels of vWF cleaving protease. In this pilot study, we have evaluated whether or not deficiencies of ADAMTS-13 were present in myelodysplastic syndromes (MDS). Moreover, we assessed if a reduction in basal levels of ADAMTS-13 may play a role in the prognosis of MDS.Patients and MethodsWe measured and compared the levels of vWF cleaving protease ADAMTS-13 in 100 patients with MDS and 35 healthy controls. Patients were divided into 2 groups according to the International Prognostic Scoring System: group I consisting of 44 patients with low-risk MDS and group II of 56 patients with high-risk MDS. Patients with high-risk and low-risk MDS presented significantly lower levels of ADAMTS-13 than controls (P < .001 and P = .0177, respectively). High-risk patients had significantly lower levels of ADAMTS-13 when compared with the low-risk group (P < .001).ResultsWe found that reduced levels of ADAMTS-13 have a relationship with overall survival (P < .001). Statistical analysis showed that ADAMTS-13 correlates with cytogenetics (P < .001) and a tendency of slight correlation with platelet count and basal levels of ADAMTS-13 (R, 0.35; P value, 0.001). Moreover, we found that levels of ADAMTS-13 have correlation with response to treatment (P < .001).ConclusionsADAMTS-13 in MDS might represent a surrogate marker of prognosis, response to therapy, or disease progression. Further studies are needed. 相似文献